Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus. Basel, 12 November 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today […]
The Future is Unwritten - Healing Arts Symposium
On November 14, 2021, leading policy advocates, artists, and researchers from cultural organizations, healthcare centers, government, and the United Nations will convene at The Metropolitan Museum of Art in New York in a call to action to acknowledge and act on the evidence base for the health benefits of the arts. The day-long Healing Arts […]
Countries commit to develop climate-smart health care at COP26 UN climate conference
November 9 – Glasgow, Scotland. A group of 47 countries have committed to develop climate-resilient and low-carbon health systems at the UN Climate Change Conference in Glasgow (COP26), in response to growing evidence of the impact of climate change on people’s health. The governments of these 47 countries, which include some of those most vulnerable […]
WHO issues emergency use listing for eighth COVID-19 vaccine
3 November 2021, Geneva: Today, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2. WHO’s EUL procedure assesses the quality, safety and efficacy of COVID-19 vaccines and is a […]
COVID-19 Virtual Press Conference
More than 5 million deaths have now been reported, and we know the real number is higher. Last week, 56 countries, from all regions, reported an increase in deaths from COVID-19 of more than 10%. Yesterday we added another new tool, with the Emergency Use Listing of Covaxin, the 8th vaccine to receive WHO validation […]
IMPACT trial data shows clear benefit in using Roche's CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer
Every year, over 604,000 women worldwide are diagnosed with cervical cancer and approximately 342,000 die from this preventable disease, caused by Infection with high-risk human papillomavirus (HPV). As recently published in the International Journal of Cancer, the IMPACT (IMproving Primary screening And Colposcopy Triage) trial demonstrated that Roche's CINtec PLUS Cytology, when used as a […]
Re-opening – additional call for experts to join the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)
Re-opening call for applications from 1 to 3 November 2021 WHO is re-opening the call for applications for three additional days to encourage additional applications from the fields of social science/anthropology/ethics/political science and biosafety/biosecurity. The call will open from 1-3 November 2021, closing at 24:00CET 3 November. Applications require a Curriculum Vitae, a cover letter, […]
New ACT-Accelerator strategy calls for US$23.4 billion international investment to solve inequities in global access to COVID-19 vaccines, tests & treatments
New ACT-Accelerator strategic plan sets out urgent actions to address crucial gaps in access to COVID-19 tests, treatments, vaccines and personal protective equipment in low- and middle-income countries, using the latest epidemiological, supply and market information. Delivering this plan is crucial to reaching globally agreed targets for COVID-19 tools, to help prevent at least 5 […]
Less than 10% of African countries to hit key COVID-19 vaccination goal
BRAZZAVILLE - 28 October - Just five African countries, less than 10% of Africa’s 54 nations, are projected to hit the year-end target of fully vaccinating 40% of their people, unless efforts to accelerate the pace take off. This comes as the Region grapples to meet rising demand for essential vaccination commodities, such as syringes. […]
WHO Director-General's opening remarks at the media briefing on COVID-19
The global number of reported cases and deaths from COVID-19 is now increasing for the first time in two months, driven by an ongoing rise in Europe that outweighs declines in other regions. The pandemic persists in large part because inequitable access to tools persists. This is the scenario that the Access to COVID-19 Tools […]
